Literature DB >> 10188240

Transformation of a type 4 encapsulated strain of Streptococcus pneumoniae.

A L Bricker1, A Camilli.   

Abstract

Streptococcus pneumoniae strain JNR.7/87 is a highly virulent, type 4 encapsulated Gram-positive bacterium whose transformability has not been tested previously, and whose genome is currently being sequenced. The strain was transformed at very low efficiency by addition of exogenous competence-stimulating peptide: However, the efficiency was too low and irreproducible to be useful in many genetic studies. Therefore, the effects on transformation efficiency of changing different components of competence-stimulating peptide-induced transformation have been examined. Screening of growth media was followed by optimization of pre-induction culture acidification, glycine concentration, and induction time. An optimized protocol was developed whereby S. pneumoniae strain JNR.7/87 was transformed reproducibly with a streptomycin resistance (SmR) marker at an efficiency of approximately 10(5) colony forming units per 10(8) cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188240     DOI: 10.1111/j.1574-6968.1999.tb13460.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  61 in total

1.  Expression of lux genes in a clinical isolate of Streptococcus pneumoniae: using bioluminescence to monitor gemifloxacin activity.

Authors:  S J Beard; V Salisbury; R J Lewis; J A Sharpe; A P MacGowan
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Bacterial Second Messenger Cyclic di-AMP Modulates the Competence State in Streptococcus pneumoniae.

Authors:  Tiffany M Zarrella; Jun Yang; Dennis W Metzger; Guangchun Bai
Journal:  J Bacteriol       Date:  2020-01-29       Impact factor: 3.490

3.  Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae.

Authors:  Ramkumar Iyer; Nitin S Baliga; Andrew Camilli
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

4.  Concerted action of lactate oxidase and pyruvate oxidase in aerobic growth of Streptococcus pneumoniae: role of lactate as an energy source.

Authors:  Hiroaki Taniai; Ken-ichiro Iida; Masanori Seki; Mitsumasa Saito; Susumu Shiota; Hiroaki Nakayama; Shin-ichi Yoshida
Journal:  J Bacteriol       Date:  2008-03-14       Impact factor: 3.490

5.  The capsule sensitizes Streptococcus pneumoniae to alpha-defensins human neutrophil proteins 1 to 3.

Authors:  Katharina Beiter; Florian Wartha; Robert Hurwitz; Staffan Normark; Arturo Zychlinsky; Birgitta Henriques-Normark
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

6.  Toll-like receptor 2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes.

Authors:  Maryse Letiembre; Hakim Echchannaoui; Philipp Bachmann; Fabrizia Ferracin; Concepción Nieto; Manuel Espinosa; Regine Landmann
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance.

Authors:  Wolfgang Haas; Jack Sublett; Deepak Kaushal; Elaine I Tuomanen
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

8.  MgrA, an orthologue of Mga, Acts as a transcriptional repressor of the genes within the rlrA pathogenicity islet in Streptococcus pneumoniae.

Authors:  Carolyn Hemsley; Elizabeth Joyce; David L Hava; Amita Kawale; Andrew Camilli
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

9.  Microarray analysis of pneumococcal gene expression during invasive disease.

Authors:  Carlos J Orihuela; Jana N Radin; Jack E Sublett; Geli Gao; Deepak Kaushal; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  The utility of affinity-tags for detection of a streptococcal protein from a variety of streptococcal species.

Authors:  Meixian Zhou; Paula Fives-Taylor; Hui Wu
Journal:  J Microbiol Methods       Date:  2007-12-15       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.